WEC
OMED

Winslow Evans & Crocker’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Winslow Evans & Crocker’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-95
Closed -$3K – 1484
2013
Q4 		$3K Buy
+95
New +$1.74K ﹤0.01% 1262

Other funds holding OMED

SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Cupps Capital Management Chicago, Illinois $231M AUM 49.73% 1-Year Est. Return

Winslow Evans & Crocker's OMED Position: Q1 2014 in Review

Winslow Evans & Crocker sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q1 2014, closing a stake of 95 shares — an estimated $3K sold.

Winslow Evans & Crocker first reported a position in OMED in Q4 2013 and held it in 1 quarter. The position peaked at $3K in Q4 2013. 55 funds tracked by Wall St. Rank hold OMED as of Q1 2014.

  • Winslow Evans & Crocker reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q1 2014 after selling out during the quarter.
  • Winslow Evans & Crocker sold 95 OncoMed Pharmaceuticals, Inc. shares in Q1 2014, an estimated $3K.
  • Winslow Evans & Crocker first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2013 and held it in 1 quarter.
  • Winslow Evans & Crocker's OncoMed Pharmaceuticals, Inc. position peaked at $3K in Q4 2013.
  • 55 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q1 2014.

Based on Winslow Evans & Crocker's 13F filing for Q1 2014, filed 11 Apr 2014.